APC and colorectal carcinoma: Aberrant activation of Wnt-β-catenin signaling (by stabilizing mutations in β-catenin, or in the adenomatous polyposis coli, APC, gene) is a hallmark of colorectal cancer (CRC) development in the majority of colon cancer patients [13,14,15].